Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
11/2005
11/22/2005CA2187174C .alpha.-substituted phenylacetic acid derivative, process for producing the same, and agricultural bactericide containing the same
11/22/2005CA2162122C Use of glycine-n,n-diacetic acid derivatives as biodegradable complexing agents for alkaline earth and heavy metal ions, and method of preparing them
11/22/2005CA2068066C Herpesvirus particles and vaccine
11/17/2005WO2005108844A2 Threaded connection for oil field applications
11/17/2005WO2005108590A2 Method for producing optically active alcohols from alkanones using a dehydrogenase of azoarcus
11/17/2005WO2005108386A1 Crystalline forms of duloxetine free base
11/17/2005WO2005108370A1 Benzene compounds
11/17/2005WO2005108355A2 Dihydrobenzothiophenes
11/17/2005WO2005107762A2 Certain chemical entities, compositions, and methods
11/17/2005WO2005085177A3 Biaryl amino acids and their use in dna binding oligomers
11/17/2005WO2005016264A3 Diamine derivatives of quinone and uses thereof
11/17/2005US20050256333 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
11/17/2005US20050256318 Process for the preparation of n-monosubstituted beta-amino alcohols
11/17/2005US20050256180 drugs such as 1 -[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide, used as antiinflammatory agents, antiarthritic agents, antipyretics or analgesics
11/17/2005US20050256174 Raf kinase inhibitors
11/17/2005US20050256170 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders
11/17/2005US20050256160 Beta-alanine derivatives and the use thereof
11/17/2005US20050256133 Thio-substituted arylmethanesulfinyl derivatives
11/17/2005US20050256116 Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/17/2005US20050256107 New substituted thiophene carboxamides, process for their preparation and their use as medicaments
11/17/2005US20050255575 Reacting a vinyl halide and an acetylene compound in the presence of a copper (1) bidentate ligand complex, e.g., Cu(1,10-phenanthrolene)(triphenylphosphine)2NO3 and a CuI/neocuproine reaction product; free of expensive palladium reagents
11/17/2005US20050253112 Luminescent compositions
11/17/2005CA2566092A1 Crystalline forms of duloxetine free base
11/17/2005CA2565695A1 Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder
11/17/2005CA2565367A1 Dihydrobenzothiophenes
11/16/2005EP1595871A2 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
11/16/2005EP1594867A2 Phenylacetamides and their use as glucokinase modulators
11/16/2005EP1594857A2 N-monoacylated o-phenylenediamines as anti-cancer agents
11/16/2005EP1594856A1 Cb 1/cb 2 receptor ligands and their use in the treatment of pain
11/16/2005EP1594846A1 Bis(hetero)aryl carboxamide derivatives for use as pgi2 antagonists
11/16/2005EP1594512A2 Compounds for the treatment of viral infection
11/16/2005EP1594508A2 Novel bicyclic compounds and compositions
11/16/2005EP1492795B1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
11/16/2005EP1487796A4 Substituted biaryl amides as c5a receptor modulators
11/16/2005EP1397129B1 Heteroaryloxy 3-substituted propanamines s serotonin and norepinephrine reuptake inhibitors
11/16/2005EP1317426B1 Beta-thio-amino acids
11/16/2005EP1257550B1 Platelet adp receptor inhibitors
11/16/2005EP1218374B1 Pharmaceutically active sulfonamide derivatives
11/16/2005CN1227244C Herbicidal benzoyl derivatives
11/15/2005US6964983 Compounds that modulate PPAR activity and methods for their preparation
11/15/2005US6964976 Amino alcohol derivatives
11/15/2005US6964939 Substituted thiene-3-yl-sulfonyl amino(thio)carbonyl-triazolin(thi)ones
11/15/2005CA2387517C Novel biaryl ether derivatives useful as monoamine reuptake inhibitors
11/15/2005CA2288637C Process for the preparation of 2-[(2-thienyl)-ethylamino-(2-halogenophe nyl)-acetonitriles
11/15/2005CA2250191C Benzothiophenes, formulations containing same, and methods
11/10/2005WO2005105884A1 Monomer, oligomer and pi-conjugated polymer compounds, and photovoltaic cells containing same
11/10/2005WO2005105777A1 Substituted thiophene amide compounds for the treatment of inflammation
11/10/2005WO2005105770A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/10/2005WO2005105764A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005WO2005105744A1 Histamine-3 receptor antagonists
11/10/2005WO2005105735A1 Phenoxyacetic acid derivatives as ppar agonists
11/10/2005WO2005105726A1 Novel compounds, their preparation and use
11/10/2005WO2005105725A1 Novel compounds, their preparation and use
11/10/2005WO2005105724A1 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/10/2005WO2005105723A1 Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/10/2005WO2005105719A1 Method for synthesizing compound and catalyst for synthesis reaction
11/10/2005WO2005095326A3 2-amino- and 2-thio-substituted 1,3-diaminopropanes
11/10/2005WO2005082871A3 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
11/10/2005WO2004071428A3 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
11/10/2005US20050250959 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/10/2005US20050250819 Inhibitors of bacterial type III protein secretion systems
11/10/2005US20050250814 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
11/10/2005US20050248154 Threaded connection for oil field applications
11/10/2005CA2566369A1 Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/10/2005CA2565184A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005CA2564258A1 Histamine-3 receptor antagonists
11/10/2005CA2562176A1 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/09/2005EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity
11/09/2005EP1216223B1 Novel dicarboxylic acid derivatives with pharmaceutical properties
11/09/2005EP1163236B1 Aromatic heterocyclic compounds as anti-inflammatory agents
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005CN1694878A Processes for the preparation of heterocyclic hydroxyamines and intermediates and catalysts for use therein
11/09/2005CN1694700A Non-nucleoside reverse transcriptase inhibitors
11/09/2005CN1226284C N-sulphonyl and N-sulphinyl phenylglycinamide
11/09/2005CN1226250C Anthracene derivatives and organic electroluminescent device made by using the same
11/08/2005US6963017 Reacting indanone compound with coupling component
11/08/2005US6963010 Hydrophobic polyamine analogs and methods for their use
11/08/2005CA2155104C Heterocyclic-substituted alkyl amide acat inhibitors
11/03/2005WO2005103033A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
11/03/2005WO2005102967A1 PROCESS FOR PRODUCING π-CONJUGATED COMPOUND
11/03/2005US20050245760 Preparing liquid-crystalline compounds, agrochemicals, pharmaceuticals or intermediates by providing stereoisomerically enriched 4-aryl-4-hydroxybutanoic acid derivatives
11/03/2005US20050245749 Method for the production of (s)-3-methylamino-1-(thien-2-yl)propan-1-ol
11/03/2005US20050245747 e.g. 2-[2-(5-chloro-benzo[b]thiophen-2-yl)-phenylmethanesulfinyl]-acetamide; autoimmune disorders, antidepressant; narcolepsy, Parkinson's, Alzheimer's disease; attention deficit hyperactivity disorder; sleep disorder, fatigue
11/03/2005US20050245615 Treating proliferative cutaneous disease using a polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; e.g. lupus; use with other biosynthesis enzyme inhibitors
11/03/2005US20050245607 N-bisaryl- and n-aryl-cylcloakylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides
11/03/2005US20050245602 Selective estrogen receptor modulators
11/03/2005US20050245583 Pesticides for crops; agriculture, horticulture
11/03/2005US20050245543 Histamine-3 receptor antagonists
11/03/2005US20050245542 Pyridazine, pyrimidine and pyrazine ethyne compounds
11/03/2005US20050245503 Therapeutic heterocycles
11/03/2005DE102005012585A1 New dibenzofuran-, dibenzothiophene- and fluorene derivatives useful in liquid crystalline media, which is useful in e.g. electro optical display elements
11/03/2005CA2562100A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1590338A2 Modulators of melanocortin receptor
11/02/2005EP1590322A1 Carbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof
11/02/2005EP1590321A2 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/02/2005EP1590319A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
11/02/2005EP1446402B1 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase
11/02/2005EP1242363B1 Cd45 inhibitors
11/02/2005EP1159261B1 Antizyme modulators and their use